Viridian Therapeutics, Inc.\DE (VRDN) Preferred Shares (2020 - 2026)

Viridian Therapeutics, Inc.\DE's Preferred Shares history runs 7 years deep, the most recent figure standing at $61.2 million for Q1 2026.

• On a quarterly basis, Preferred Shares fell 52.08% year-over-year to $61.2 million in Q1 2026; TTM through Mar 2026 was $61.2 million, a 52.08% decrease from a year earlier, with the FY2025 full-year figure at $70.9 million, up 15.82% from the prior year.
• Preferred Shares retreated to $61.2 million in Q1 2026 per VRDN's latest filing, from $70.9 million in the prior quarter.
• Across five years, Preferred Shares topped out at $128.3 million in Q4 2023 and bottomed at $15.7 million in Q2 2022.
• The 5-year median for Preferred Shares is $78.2 million (2023), against an average of $84.1 million.
• Across the five-year window, Preferred Shares soared 399.3% in 2023 and tumbled 52.3% in 2024, its largest moves.
• Year by year, Preferred Shares stood at $85.5 million in 2022, then surged by 50.09% to $128.3 million in 2023, then tumbled by 52.3% to $61.2 million in 2024, then advanced by 15.82% to $70.9 million in 2025, then dropped by 13.66% to $61.2 million in 2026.
• Per Business Quant, the three latest VRDN Preferred Shares figures stand at $61.2 million (Q1 2026), $70.9 million (Q4 2025), and $61.2 million (Q3 2025).